References
- Will R G, Ironside J W, Zeidler M, Cousens S N, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith P G. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921–5
- Zeidler M, Stewart G E, Barraclough C R, Bateman D E, Bates D, Burn D J, Colchester A C, Durward W, Fletcher N A, Hawkins S A, Mackenzie J M, Will R G. New variant Creutzfeldt-Jakob disease; neurological features and diagnostic tests. Lancet 1997; 350: 903–7
- Zeidler M, Johnstone E C, Bamber R WK, Dickens C M, Creutzfeldt-Jakob disease F isher, Francis A F, Goldbeck R, Higgo R, Johnson-Sabine E C, Lodge G J, McGarry P, Mitchell S, Tario L, Turner M, Ryley P, Will R G. New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet 1997; 350: 90
- Lasmézas C I, Ironside J W, Chiach C, Demaimay R, Adjou K T, Lamoury F, Dormont D, Robain O. BSE trans mission to macaques. Nature 1996; 381: 743–4
- Hill A F, Desbruslais M, Joiner S, Sidle K CL, Gowland L, Collinge J. The same prion strain causes vCJD and BSE. Nature 1997; 389: 448–50
- Collinge J, Palmer M S, Sidle K CL, Hill A F, Gowland I, Meads J, Asante E, Bradley R, Doey L J, Lantos P L. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature 1995; 378: 779–83
- Bruce M E, Will R G, Ironside J W, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock C J. Transmissions to mice indicate that “new variant” CJD is caused by the BSE agent. Atawre 1997; 389: 498–501
- Scott M, Will R G, Ironside J W, Nguyen H-OB, Tremblay P, DeArmond S J, Prusiner S B. Compelling transgenic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Nat Acad Sci USA 1999; 96: 15137–15142
- Almond J, Pattison J. Human BSE. Nature 1997; 389: 437–8
- Hill A F, Zeidler M, Ironside J W, Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997; 349: 99–100
- Hilton D A, Fathers E, Edwards P, Ironside J W, Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998; 352: 703–4
- Van Keulen L JM, Schreuder R EC, Meloen R H, Mooij-Harkes G, Vromans M EW, Langeveld J P. Im-munohistochemical detection of prion protein in lymphoid tissues of sheep with natural scrapie. J Clin Microbiol 1996; 34: 1228–31, M
- Brown K l, Stewart L, Ritchie D L, Mabbott N A, Williams A, Fraser H, Morrison W I, Bruce M E. Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nat Med 1999; 5: 1308–1312
- Cousens S, Vynnycky E, Zeidler M, Will R G, Smith P G. Predicting the CJD epidemic in humans. Nature 1997; 385: 197–8
- Schmerr M J, Jenny A, Cutlip R C. Use of capillary sodium dodecyl sulfate gel electrophoresis to detect the prion protein extracted from scrapie infected sheep. J Chromatogr 1997; 697: 223–229
- Ironside J W, Head M W. Inhibition of prion-pro-tein conversion: a therapeutic tool?. Trends Microbiol 1999; 8: 6–8